Response to Letter to the Editor Regarding "Efficacy of Chinese Medicine on Postoperative Rehabilitation of Non-Small Cell Lung Cancer (NSCLC), a Randomized Controlled Study" in Integrative Cancer Therapies [0.03%]
针灸加速非小细胞肺癌(NSCLC)术后恢复的随机对照研究——致《综合肿瘤治疗》杂志“中医药对非小细胞肺癌术后康复的有效性”一文作者的回复
Yifeng Gu,Yichao Wang,Huiling Zhou et al.
Yifeng Gu et al.
Comment on "Efficacy of Chinese Medicine on Postoperative Rehabilitation of Non-Small Cell Lung Cancer (NSCLC), a Randomized Controlled Study" [0.03%]
关于“中医药对非小细胞肺癌术后康复的疗效——随机对照研究”的评论
Xiaojie Zhou,Junlei Chen,Yuying Li et al.
Xiaojie Zhou et al.
Impact of Sodium Ascorbate High Dose on Quality of Life and Pain in Patients Diagnosed With and Treated for Terminal Cancer (Real-World Data Study) [0.03%]
大剂量维生素C对终末期癌症患者生活质量及疼痛的干预效果研究(真实世界证据研究)
Hugo Mario Galindo Salom,Carlos Alberto Carrillo Bravo,Helber Armando Prieto Lozano et al.
Hugo Mario Galindo Salom et al.
Cancer pain is a complex issue of significant importance in daily clinical practice, requiring a multidimensional approach. Approximately 90% of cancer pain cases can be effectively managed through the appropriate and often combined use of ...
Observational Study
Integrative cancer therapies. 2026 Jan-Dec:25:15347354251414640. DOI:10.1177/15347354251414640 2026
Response to Letter Regarding "Herbal Medicine Combined With Chemotherapy in Advanced NSCLC" [0.03%]
“中医药联合化疗治疗晚期肺癌”的来信回复
Dong-Hyeon Kim,Keon-Jun Lee,So-Jung Park
Dong-Hyeon Kim
Adjuvant Chemotherapy with Traditional Chinese Herbal Granules Versus Placebo in Resected Non-Small Cell Lung Cancer: Updated Survival Analysis of a Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial [0.03%]
手术后肺癌患者使用中药口服汤剂与安慰剂辅助化疗的疗效对比:多中心随机双盲对照试验的随访分析
Yichao Wang,Lijing Jiao,Zhiwei Chen et al.
Yichao Wang et al.
Background: The NALLC trial (NCT01441752) demonstrated that postoperative adjuvant chemotherapy combined with traditional Chinese medicine (TCM) improved the quality of life (QoL) and survival in resected stage Ib-IIIa no...
Randomized Controlled Trial
Integrative cancer therapies. 2026 Jan-Dec:25:15347354251409081. DOI:10.1177/15347354251409081 2026
Deepening the Framework: A TCM-Informed Perspective on Qualitative Experiences in Integrative Psycho-Oncology for Colorectal Cancer Survivors [0.03%]
深化整合心理肿瘤学框架:结直肠癌幸存者质性体验的中医观视角
Mingyue Chen,Yan Han,Fenxiang Zhang
Mingyue Chen
Exercise as Precision Medicine: Targeting HER2/CD44-Driven Therapy Resistance in Breast Cancer (A Mini Review) [0.03%]
精准医疗中的运动:针对乳腺癌中HER2/CD44驱动的治疗耐药性( minireview)
Fatemeh Alsadat Edalat Haghi,Maryam Koushkie Jahromi
Fatemeh Alsadat Edalat Haghi
Despite advances in HER2-targeted therapies and CSC-directed agents, resistance remains a major barrier in breast cancer. Synthesize evidence for exercise as a precision strategy to disrupt HER2/CD44-driven resistance circuits. Preclinical ...
Modified Wen Luo Tong Alleviated Chemotherapy-Induced Peripheral Neuropathy via Regulating the CX3CL1/CX3CR1 Axis Through Inhibiting NF-κB and STAT3 Pathways [0.03%]
Modified Wen Luo Tong通过抑制NF-κB和STAT3通路调节CX3CL1/CX3CR1轴缓解化疗诱导的外周神经病变
Feize Wu,Jianjing Zhang,Hongyan Wang et al.
Feize Wu et al.
Background: Chemotherapy-induced peripheral neuropathy (CIPN) is a serious clinical problem with no widely applicable solutions. Modified Wen Luo Tong (mWLT) was designed specifically for paclitaxel-related CIPN, yet its ...